Drive Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Buy
+953
New +$353K 0.07% 255
2026
Q1
Sell
-659
Closed -$231K 390
2025
Q4
$231K Buy
+659
New +$223K 0.05% 329
2024
Q4
Sell
-925
Closed -$481K 352
2024
Q3
$481K Buy
925
+13
+1% +$6.95K 0.13% 132
2024
Q2
$494K Buy
912
+30
+3% +$15.9K 0.13% 135
2024
Q1
$457K Buy
882
+35
+4% +$17.4K 0.13% 149
2023
Q4
$399K Buy
847
+70
+9% +$32.4K 0.13% 151
2023
Q3
$338K Buy
777
+219
+39% +$99.3K 0.12% 155
2023
Q2
$248K Sell
558
-107
-16% -$49.4K 0.09% 208
2023
Q1
$306K Buy
665
+90
+16% +$42.8K 0.13% 171
2022
Q4
$295K Buy
+575
New +$292K 0.15% 160

Other funds holding ELV

Drive Wealth Management's ELV Position: Q2 2026 in Review

Drive Wealth Management opened a new position in Elevance Health (ELV) in Q2 2026: 953 shares worth $369K. The stake represents 0.07% of the portfolio and ranks #255 among its holdings. This is a return to the name: Drive Wealth Management previously reported a position in ELV as recently as Q4 2025.

Drive Wealth Management first reported a position in ELV in Q4 2022 and has held it in 10 quarters since. The position peaked at $494K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Drive Wealth Management held 953 shares of Elevance Health worth $369K as of Q2 2026.
  • Elevance Health was a new Drive Wealth Management position in Q2 2026.
  • Elevance Health made up 0.07% of Drive Wealth Management's portfolio in Q2 2026, its #255 holding.
  • Drive Wealth Management first reported a position in Elevance Health in Q4 2022 and has held it in 10 quarters since.
  • Drive Wealth Management's Elevance Health position peaked at $494K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.